AbCellera Biologics Inc. (ABCL) Live Share Price, Invest From India

AbCellera Biologics Inc. Stock Performance

as on August 1, 2026 at 3:35 am IST

Day's Low
Day's High
$5.51
Day's Price Range
$5.87
$5.58
1.25%
Downside
5.20%
Upside
52 Week's Low
52 Week's High
$2.75
52-Week Price Range
$8.44
$5.58
50.81%
Downside
51.25%
Upside

AbCellera Biologics Inc. share price movements today

Previous Close: $5.69
Open: $5.70
Volume: 2.2M
Day's Low - High: $5.51 - $5.87
52 Week Low - High: $2.75 - $8.44

AbCellera Biologics Inc. Historical Returns

1 Month Return: -29.08 %
3 Month Return: + 21.67 %
1 Year Return: + 20.58 %
3 Year Return: -30.27 %
5 Year Return: -64.47 %

AbCellera Biologics Inc. Stock Fundamentals & Key Indicators

Check AbCellera Biologics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.6B

EPS (TTM)

-0.6267

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

-181.74%

Return On Equity TTM

-14.68%

AbCellera Biologics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of AbCellera Biologics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
AbCellera Biologics Inc.	BUY	$1.6B	-64.47%	NA	-181.74%	NA
Revolution Medicines Inc.	BUY	$39.1B	531.7%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$124.5B	139.77%	28.41	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$72.9B	21.02%	16.29	29.65%	0.54%

Stock Returns calculator for AbCellera Biologics Inc. Stock including INR - Dollar returns

The AbCellera Biologics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

AbCellera Biologics Inc. investment value today

Current value as on today

₹1,36,038

Returns

₹36,038

(+36.04%)

Returns from AbCellera Biologics Inc. Stock

₹24,832 (+24.83%)

Dollar Impact

₹11,205 (+11.21%)

Analyst Recommendation on AbCellera Biologics Inc. Stock

Based on 15 analysts

BUY

93.33%

Buy

6.67%

Hold

0.00%

Sell

Based on 15 analysts, 93.33% of analysts recommend a 'BUY' rating for AbCellera Biologics Inc.. Average target price of $10.5

AbCellera Biologics Inc. Share Price Target

Get share price movements and forecasts by analysts on AbCellera Biologics Inc..

What analysts predicted

46.86%UPSIDE

Target Price

$10.5

Current Price

$5.58

Analyzed by

15 Analysts

Target

$10.50

AbCellera Biologics Inc. target price $10.5, a slight upside of 46.86% compared to current price of $5.58. According to 15 analysts rating.

Indian Investors' Interest in AbCellera Biologics Inc. Stock

Investment in AbCellera Biologics Inc. Shares on INDmoney has dropped by -27.80% in the last 30 days, indicating reduced investment activity.

Time period: July 1, 2026 to July 31, 2026

Change:-27.80% versus previous 30 day period

Search interest for AbCellera Biologics Inc. Stock has decreased by -9% in the last 30 days, reflecting a downward trend in search activity.

Time period: July 1, 2026 to July 31, 2026

Change:-9% versus previous 30 day period

AbCellera Biologics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	9	9	7	6	5	4	17	8	44	8
Gross Profit	9	9	7	6	5	4	17	8	36	0
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-47	-40	-36	-51	-34	-45	-34	-57	-8	-43
Net Profit Margin	-513.67%	-407.98%	-504.30%	-785.42%	-677.43%	-1077.24%	-203.27%	-637.84%	-19.94%	-519.12%

AbCellera Biologics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	8	11	233	11	485	38	28	75
Gross Profit	8	11	206	11	418	38	28	46
Operating Income	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-
Net Income	0	-2	118	-2	158	-146	-162	-146
Net Profit Margin	3.50%	-19.04%	51.00%	-19.04%	32.66%	-385.00%	-564.83%	-194.88%

Global Institutional Holdings in AbCellera Biologics Inc.

Funds	Holdings
Capital World Investors	4.38%
State Street Corp	0.23%
ArrowMark Colorado Holdings, LLC (ArrowMark Partners)	1.34%
Morgan Stanley - Brokerage Accounts	0.73%
Renaissance Technologies Corp	0.49%

See all

Insights on AbCellera Biologics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 385.4% return, outperforming this stock by 364.8%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 589.2% return, outperforming this stock by 619.5%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 44.85M → 8.31M (in $), with an average decrease of 81.5% per quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -8.94M → -43.16M (in $), with an average decrease of 382.6% per quarter
NEGATIVE IMPACT
Price Dip
In the last 1 month, ABCL stock has moved down by -31.3%

About AbCellera Biologics Inc.

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; AbbVie Inc.; Jazz Pharmaceuticals plc to develop T-cell engaging (TCE) multispecific antibodies; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Organisation	AbCellera Biologics Inc.
Headquarters	150 W 4th Avenue, Vancouver, BC, Canada, V5Y 1G6
Industry	Biotechnology
CEO	Dr. Carl L.G. Hansen Ph.D.
E-voting on shares	Click here to vote

Key Management of AbCellera Biologics Inc.

Name	Title
Dr. Carl L.G. Hansen Ph.D.	CEO, President & Chairperson
Mr. Andrew Booth M.B.A.	Chief Financial Officer
Dr. Veronique Lecault Ph.D.	CTO & Director
Mr. Tryn T. Stimart Esq., J.D., M.Sc.	Chief Legal Officer, Chief Compliance Officer, Corporate Secretary & Privacy Officer

FAQs

What is AbCellera Biologics Inc. share price today?

AbCellera Biologics Inc. share price today is $5.58 as on July 31, 2026 at 10:05 pm IST. AbCellera Biologics Inc. share today touched a day high of $5.87 and a low of $5.51.

What is the 52 week high and 52 week low for AbCellera Biologics Inc. share?

AbCellera Biologics Inc. share touched a 52 week high of $8.44 on January 1, 1970 and a 52 week low of $2.75 on January 1, 1970. AbCellera Biologics Inc. stock price today i.e. July 31, 2026 at 10:05 pm IST is trending at $5.58,which is 33.89% down from its 52 week high and 103.28% up from its 52 week low.

What is AbCellera Biologics Inc.'s market capitalisation today?

AbCellera Biologics Inc. market capitalisation is $0.00T as on July 31, 2026 at 10:05 pm IST.

How to invest in AbCellera Biologics Inc. Stock (ABCL) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for AbCellera Biologics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in AbCellera Biologics Inc. Shares that will get you 0.2688 shares as per AbCellera Biologics Inc. share price of $5.58 per share as on July 31, 2026 at 10:05 pm IST.

What is the minimum amount required to buy AbCellera Biologics Inc. Stock (ABCL) from India?

Indian investors can start investing in AbCellera Biologics Inc. (ABCL) shares with as little as ₹95.38 or $1 (as of July 31, 2026 at 10:05 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹953.80 in AbCellera Biologics Inc. stock (as per the Rupee-Dollar exchange rate as on July 31, 2026 at 10:05 pm IST). Based on AbCellera Biologics Inc. share’s latest price of $5.58 as on July 31, 2026 at 10:05 pm IST, you will get 1.7921 shares of AbCellera Biologics Inc.. Learn more about fractional shares .

What are the returns that AbCellera Biologics Inc. has given to Indian investors in the last 5 years?

AbCellera Biologics Inc. stock has given -64.47% share price returns and 28.92% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?